Sumita Ray - 01 Nov 2023 Form 4 Insider Report for Vaxxinity, Inc.

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VAXX	Employee Stock option (right to buy)	Award	$0	+425,000		$0.000000	425,000	01 Nov 2023	Class A Common Stock	425,000	$1.17	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	These options are subject to a four-year vesting schedule, with 25% vesting one year after the vesting commencement date of October 1, 2023 and the remainder vesting in equal quarterly installments, subject to the Reporting Person's continued service.